Nomura Asset Management Co. Ltd. cut its position in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 2.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 54,428 shares of the medical equipment provider’s stock after selling 1,569 shares during the period. Nomura Asset Management Co. Ltd. owned approximately 0.06% of Varian Medical Systems worth $5,446,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Caisse DE Depot ET Placement DU Quebec boosted its stake in Varian Medical Systems by 4.2% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 14,735 shares of the medical equipment provider’s stock valued at $1,481,000 after buying an additional 600 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in Varian Medical Systems by 7.4% during the third quarter. Envestnet Asset Management Inc. now owns 155,610 shares of the medical equipment provider’s stock valued at $15,572,000 after buying an additional 10,661 shares during the last quarter. Convergence Investment Partners LLC bought a new position in Varian Medical Systems during the third quarter valued at approximately $219,000. BB&T Investment Services Inc. boosted its stake in Varian Medical Systems by 48.9% during the third quarter. BB&T Investment Services Inc. now owns 5,650 shares of the medical equipment provider’s stock valued at $568,000 after buying an additional 1,855 shares during the last quarter. Finally, Sompo Japan Nipponkoa Asset Management CO. LTD. bought a new position in Varian Medical Systems during the third quarter valued at approximately $2,896,000. 99.15% of the stock is owned by institutional investors.

Shares of Varian Medical Systems, Inc. (NYSE VAR) traded up $0.02 during mid-day trading on Friday, reaching $111.98. The company’s stock had a trading volume of 491,643 shares, compared to its average volume of 669,138. Varian Medical Systems, Inc. has a fifty-two week low of $76.94 and a fifty-two week high of $113.58. The stock has a market capitalization of $10,257.43, a P/E ratio of 29.70, a PEG ratio of 3.29 and a beta of 0.67.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The company had revenue of $739.00 million for the quarter, compared to analysts’ expectations of $741.69 million. During the same quarter last year, the company earned $1.03 earnings per share. The company’s revenue for the quarter was down 1.1% on a year-over-year basis. research analysts expect that Varian Medical Systems, Inc. will post 4.26 earnings per share for the current year.

In other news, insider Dow R. Wilson sold 15,059 shares of the stock in a transaction that occurred on Friday, October 6th. The stock was sold at an average price of $102.40, for a total value of $1,542,041.60. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Kolleen T. Kennedy sold 931 shares of the stock in a transaction that occurred on Wednesday, October 18th. The stock was sold at an average price of $105.00, for a total value of $97,755.00. Following the completion of the sale, the executive vice president now owns 27,531 shares in the company, valued at $2,890,755. The disclosure for this sale can be found here. Over the last quarter, insiders sold 26,771 shares of company stock worth $2,762,740. Company insiders own 0.91% of the company’s stock.

A number of equities research analysts have issued reports on VAR shares. Zacks Investment Research downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. Citigroup upped their price objective on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a research report on Monday, October 30th. Royal Bank Of Canada restated a “hold” rating and set a $100.00 price objective on shares of Varian Medical Systems in a research report on Friday, September 1st. BidaskClub upgraded Varian Medical Systems from a “sell” rating to a “hold” rating in a research report on Saturday, August 12th. Finally, BTIG Research restated a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, October 29th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and one has issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $98.39.

TRADEMARK VIOLATION WARNING: This article was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/12/09/nomura-asset-management-co-ltd-reduces-position-in-varian-medical-systems-inc-var.html.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Stock Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related stocks with our FREE daily email newsletter.